Atlas FDA

DEXCOM SEVEN AND SEVEN PLUS SYSTEM

FDA premarket approval P050012/S025 · decided 2010-07-15

Approval details

PMA number
P050012
Supplement
S025
Supplement type
Special (Immediate Track)
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
DEXCOM SEVEN AND SEVEN PLUS SYSTEM
Generic name
Sensor, glucose, invasive
Applicant
Dexcom, Inc.
Date received
2010-06-15
Decision date
2010-07-15
Days to decision
30 days
Decision code
APPR
Product code
MDS
Advisory committee
Clinical Chemistry
Expedited review
No
Location
San Diego, CA
Statement
APPROVAL FOR MODIFICATIONS TO THE DEVICE LABELING TO INCLUDE MORE EMPHASIS ON THE ALERT TO USERS ABOUT THE POTENTIAL FOR THE TIPS OF SENSORS BREAKING OFF AND TO PROVIDE RECOMMENDATIONS TO USERS REGARDING THEIR ACTIONS SHOULD THIS OCCUR.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Stelo Glucose Biosensor System (K260935)Dexcom, Inc.2026-06-12
Dexcom G7 Continuous Glucose Monitoring System;Dexcom G7 15 Day Continuous Glucose Monitoring System (K261402)Dexcom, Inc.2026-06-08
Stelo Glucose Biosensor System (K261359)Dexcom, Inc.2026-05-21
Dexcom G7 Continuous Glucose Monitoring (CGM) System; Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System (K253737)Dexcom, Inc.2026-02-03
Dexcom G7 Continuous Glucose Monitoring (CGM) System, Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System (K253710)Dexcom, Inc.2025-12-17
Dexcom Smart Basal (K252818)Dexcom, Inc.2025-11-18
Dexcom G7 15 Day Continuous Glucose Monitoring System (K243214)Dexcom, Inc.2025-04-09
Dexcom G7 Continuous Glucose Monitoring System (K240902)Dexcom, Inc.2024-04-23